Briefing / Office of Health Economics
Citation Profile [Updated: 2024-03-05 07:42:34]
5 Years H Index
6
Impact Factor (IF)
0.5
5 Years IF
0.15
Data available in this
report
[Raw
data] [50 most cited papers]
[50 most relevant papers]
[cites used to compute IF]
[Recent
citations ][Frequent citing
series ] [more data in
EconPapers]
[
trace new citations] [Missing
citations? Add them now]
[Incorrect content? Let us
know]
Main indicators
Raw Data
| IF | AIF | CIF | IF5 | DOC | CDO | CIT | NCI | CCU | D2Y | C2Y | D5Y | C5Y | SC | %SC | CiY | II | AII | |
| 1970 | 0 | 8 | 8 | 0 | 0 | |||||||||||||
| 1974 | 0 | 1 | 9 | 0 | 0 | |||||||||||||
| 1975 | 0 | 2 | 11 | 0 | 0 | |||||||||||||
| 1976 | 0 | 1 | 12 | 0 | 0 | |||||||||||||
| 1977 | 0 | 1 | 13 | 0 | 0 | |||||||||||||
| 1978 | 0 | 3 | 16 | 0 | 0 | |||||||||||||
| 1979 | 0 | 2 | 18 | 0 | 0 | |||||||||||||
| 1980 | 0 | 3 | 21 | 0 | 0 | |||||||||||||
| 1981 | 0 | 5 | 26 | 0 | 0 | |||||||||||||
| 1982 | 0 | 2 | 28 | 0 | 0 | |||||||||||||
| 1983 | 0 | 1 | 29 | 0 | 0 | |||||||||||||
| 1985 | 0 | 1 | 30 | 0 | 0 | |||||||||||||
| 1988 | 0 | 2 | 32 | 0 | 0 | |||||||||||||
| 1989 | 0 | 1 | 33 | 0 | 0 | |||||||||||||
| 1990 | 0 | 0.17 | 0 | 0 | 3 | 36 | 0 | 0 | 3 | 4 | 0 | 0 | 0.1 | |||||
| 1991 | 0 | 0.15 | 0 | 0 | 2 | 38 | 0 | 0 | 4 | 6 | 0 | 0 | 0.1 | |||||
| 1992 | 0.2 | 0.13 | 0.03 | 0.13 | 1 | 39 | 0 | 1 | 1 | 5 | 1 | 8 | 1 | 0 | 0 | 0.09 | ||
| 1993 | 0 | 0.17 | 0.03 | 0 | 1 | 40 | 0 | 1 | 2 | 3 | 9 | 0 | 0 | 0.1 | ||||
| 1994 | 0 | 0.17 | 0 | 0 | 2 | 42 | 0 | 2 | 2 | 8 | 0 | 0 | 0.08 | |||||
| 1995 | 0 | 0.23 | 0 | 0 | 1 | 43 | 7 | 2 | 3 | 9 | 0 | 0 | 0.13 | |||||
| 1997 | 0 | 0.28 | 0 | 0 | 3 | 46 | 3 | 3 | 1 | 5 | 0 | 0 | 0.15 | |||||
| 1998 | 0.67 | 0.32 | 0.18 | 0.43 | 3 | 49 | 5 | 9 | 12 | 3 | 2 | 7 | 3 | 1 | 11.1 | 6 | 2 | 0.18 |
| 2003 | 0 | 0.53 | 0 | 0 | 1 | 50 | 0 | 16 | 0 | 3 | 0 | 0 | 0.3 | |||||
| 2004 | 1 | 0.6 | 0.04 | 1 | 1 | 51 | 1 | 2 | 18 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 0.36 | |
| 2006 | 0 | 0.59 | 0.02 | 0 | 2 | 53 | 0 | 1 | 21 | 1 | 2 | 0 | 0 | 0.34 | ||||
| 2008 | 0 | 0.59 | 0.02 | 0.25 | 5 | 58 | 19 | 1 | 24 | 2 | 4 | 1 | 0 | 0 | 0.29 | |||
| 2009 | 0.2 | 0.59 | 0.05 | 0.13 | 6 | 64 | 37 | 3 | 27 | 5 | 1 | 8 | 1 | 2 | 66.7 | 2 | 0.33 | 0.33 |
| 2012 | 0 | 0.68 | 0.08 | 0.36 | 1 | 65 | 0 | 5 | 45 | 0 | 11 | 4 | 0 | 0 | 0.36 | |||
| 2014 | 0 | 0.67 | 0.15 | 0.43 | 1 | 66 | 1 | 10 | 66 | 1 | 7 | 3 | 1 | 10 | 1 | 1 | 0.34 | |
| 2015 | 0 | 0.66 | 0.06 | 0 | 1 | 67 | 0 | 4 | 70 | 1 | 2 | 0 | 0 | 0.36 | ||||
| 2016 | 0.5 | 0.65 | 0.04 | 0.33 | 2 | 69 | 0 | 3 | 73 | 2 | 1 | 3 | 1 | 0 | 0 | 0.35 | ||
| 2017 | 0 | 0.62 | 0.09 | 0 | 7 | 76 | 9 | 7 | 80 | 3 | 5 | 3 | 42.9 | 4 | 0.57 | 0.35 | ||
| 2018 | 0 | 0.61 | 0.05 | 0 | 3 | 79 | 5 | 4 | 84 | 9 | 11 | 1 | 25 | 0 | 0.35 | |||
| 2019 | 0 | 0.63 | 0.01 | 0 | 4 | 83 | 6 | 1 | 85 | 10 | 14 | 0 | 0 | 0.36 | ||||
| 2020 | 0.29 | 0.71 | 0.05 | 0.12 | 2 | 85 | 0 | 4 | 89 | 7 | 2 | 17 | 2 | 0 | 0 | 0.76 | ||
| 2021 | 0.5 | 0.98 | 0.1 | 0.39 | 3 | 88 | 0 | 9 | 98 | 6 | 3 | 18 | 7 | 0 | 0 | 0.4 | ||
| 2022 | 0 | 0.76 | 0.08 | 0.32 | 1 | 89 | 0 | 7 | 105 | 5 | 19 | 6 | 0 | 0 | 0.24 | |||
| 2023 | 0.5 | 0.61 | 0.07 | 0.15 | 1 | 90 | 0 | 6 | 111 | 4 | 2 | 13 | 2 | 0 | 0 | 0.22 |
| IF: | Two years Impact Factor: C2Y / D2Y |
| AIF: | Average Impact Factor for all series in RePEc in year y |
| CIF: | Cumulative impact factor |
| IF5: | Five years Impact Factor: C5Y / D5Y |
| DOC: | Number of documents published in year y |
| CDO: | Cumulative number of documents published until year y |
| CIT: | Number of citations to papers published in year y |
| NCI: | Number of citations in year y |
| CCU: | Cumulative number of citations to papers published until year y |
| D2Y: | Number of articles published in y-1 plus y-2 |
| C2Y: | Cites in y to articles published in y-1 plus y-2 |
| D5Y: | Number of articles published in y-1 until y-5 |
| C5Y: | Cites in y to articles published in y-1 until y-5 |
| SC: | selft citations in y to articles published in y-1 plus y-2 |
| %SC: | Percentage of selft citations in y to articles published in y-1 plus y-2 |
| CiY: | Cites in year y to documents published in year y |
| II: | Immediacy Index: CiY / Documents. |
| AII: | Average Immediacy Index for series in RePEc in year y |
50 most cited documents in this series
| # | Year | Title | Cited |
|---|---|---|---|
| 1 | 2009 | Why Should Economic Evaluations of Medical Innovations Have a Societal Perspective?. (2009). Johannesson, Magnus ; Zethraeus, N ; Kobelt, G ; Jonsson, L. In: Briefings. RePEc:ohe:briefg:000228. Full description at Econpapers || Download paper | 13 |
| 2 | 2009 | Deliberative Processes in Decisions about Health Care Technologies. (2009). Culyer, Anthony. In: Briefings. RePEc:ohe:briefg:000231. Full description at Econpapers || Download paper | 11 |
| 3 | 2008 | The Market for Biosimilars: Evolution and Policy Options. (2008). Towse, Adrian ; Mestre-Ferrandiz, J ; Chauhan, D. In: Briefings. RePEc:ohe:briefg:000238. Full description at Econpapers || Download paper | 9 |
| 4 | 2008 | New Guidelines for Economic Evaluation in Germany and the United Kingdom: Are We Any Closer to Developing International Standards?. (2008). Rutten, F ; Drummond, M F. In: Briefings. RePEc:ohe:briefg:000237. Full description at Econpapers || Download paper | 8 |
| 5 | 2009 | Access Mechanisms for Orphan Drugs: A Comparative Study of Selected European Countries. (2009). Garau, Martina ; Mestre-Ferrandiz, J. In: Briefings. RePEc:ohe:briefg:000227. Full description at Econpapers || Download paper | 8 |
| 6 | 1995 | Handling Uncertainty in the Results of Economic Evaluation. (1995). Briggs, A. In: Briefings. RePEc:ohe:briefg:000410. Full description at Econpapers || Download paper | 8 |
| 7 | 2017 | Additional Elements of Value for Health Technology Assessment Decisions. (2017). Towse, Adrian ; Karlsberg, Sarah ; Karlsberg Schaffer, Sarah ; Fischer, A ; Masterson, R ; Mestre-Ferrandiz, J ; Henshall, C ; West, P. In: Briefings. RePEc:ohe:briefg:001851. Full description at Econpapers || Download paper | 6 |
| 8 | 1998 | Trends in Economic Evaluation. (1998). Pritchard, C. In: Briefings. RePEc:ohe:briefg:000444. Full description at Econpapers || Download paper | 6 |
| 9 | 2009 | American Exceptionalism and American Health Care: Implications for the US Debate on Cost-Effectiveness Analysis. (2009). Neumann, P J. In: Briefings. RePEc:ohe:briefg:000232. Full description at Econpapers || Download paper | 4 |
| 10 | 2018 | Multi-Indication Pricing (MIP): Practical Solutions and Steps to Move Forward. (2018). Neri, Margherita ; Garau, Martina ; Towse, A. In: Briefings. RePEc:ohe:briefg:002084. Full description at Econpapers || Download paper | 4 |
| 11 | 1998 | From Efficacy to Cost-Effectiveness. (1998). Towse, Adrian ; Drummond, M F. In: Briefings. RePEc:ohe:briefg:000438. Full description at Econpapers || Download paper | 3 |
| 12 | 2019 | 2018 OHE Annual Report to the Charity Commission. (2019). Of, Office. In: Briefings. RePEc:ohe:briefg:002218. Full description at Econpapers || Download paper | 3 |
| 13 | 2019 | How Should We Measure Quality of Life Impact in Rare Disease? Recent Learnings in Spinal Muscular Atrophy. (2019). Sampson, Christopher ; Garau, M. In: Briefings. RePEc:ohe:briefg:002146. Full description at Econpapers || Download paper | 3 |
| 14 | 2009 | How Fair? Competition between Independent and NHS Providers to Supply Non-Emergency Hospital Care to NHS Patients in England. (2009). Sussex, J. In: Briefings. RePEc:ohe:briefg:000230. Full description at Econpapers || Download paper | 3 |
| 15 | 1975 | Infant and Child Health. (1975). Of, Office . In: Briefings. RePEc:ohe:briefg:000253. Full description at Econpapers || Download paper | 2 |
| 16 | 1997 | The Pros and Cons of Modelling in Economic Evaluation. (1997). Of, Office . In: Briefings. RePEc:ohe:briefg:000428. Full description at Econpapers || Download paper | 2 |
| 17 | 2004 | Developments in Economic Evaluation in Health Care: A Review of HEED. (2004). Pritchard, C. In: Briefings. RePEc:ohe:briefg:000492. Full description at Econpapers || Download paper | 2 |
| 18 | 2014 | What is the Role of HTA for Biosimilars?. (2014). Towse, Adrian ; Mestre-Ferrandiz, J. In: Briefings. RePEc:ohe:briefg:000075. Full description at Econpapers || Download paper | 2 |
| 19 | 1997 | Regulating Prices Paid by the NHS for Medicines Supplied by the UK-Based Pharmaceutical Industry. (1997). Towse, Adrian ; Cave, M. In: Briefings. RePEc:ohe:briefg:000427. Full description at Econpapers || Download paper | 2 |
| 20 | 2008 | Challenges and Opportunities for Improving Benefit-Risk Assessment of Pharmaceuticals from an Economic Perspective. (2008). Garrison, L ; Cross, J T. In: Briefings. RePEc:ohe:briefg:000239. Full description at Econpapers || Download paper | 2 |
| 21 | 2017 | Incentives for New Drugs to Tackle Anti-Microbial Resistance. (2017). Towse, Adrian ; Mestre-Ferrandiz, J ; Ferraro, J. In: Briefings. RePEc:ohe:briefg:001842. Full description at Econpapers || Download paper | 2 |
| 22 | 1994 | The Impact of Behavioural and Biomedical Advance on Health Trends over the Next 25 Years. (1994). Hall, M. In: Briefings. RePEc:ohe:briefg:000407. Full description at Econpapers || Download paper | 1 |
| 23 | 2017 | Transferability of HTA. (2017). Towse, Adrian ; Hampson, Grace ; Henshall, C ; Barnsley, P. In: Briefings. RePEc:ohe:briefg:001837. Full description at Econpapers || Download paper | 1 |
| 24 | 2020 | 2019 OHE Annual Report to the Charity Commission. (2020). Of, Office. In: Briefings. RePEc:ohe:briefg:002315. Full description at Econpapers || Download paper | 1 |
| 25 | 1979 | Immunisation for Everyone ââ¬â The Polio Experience. (1979). Of, Office . In: Briefings. RePEc:ohe:briefg:000300. Full description at Econpapers || Download paper | 1 |
| 26 | 2018 | OHE Annual Report to the Charity Commission for the Year 2017. (2018). Of, The Office. In: Briefings. RePEc:ohe:briefg:002079. Full description at Econpapers || Download paper | 1 |
| 27 | 1993 | The Impact of Unemployment on Health. (1993). Griffin, J. In: Briefings. RePEc:ohe:briefg:000401. Full description at Econpapers || Download paper | 1 |
| 28 | 2017 | Assessing Value, Budget Impact and Affordability to Inform Discussions on Access and Reimbursement: Principles and Practice, with Special Reference to High Cost Technologies. (2017). Towse, Adrian ; Hampson, Grace ; Henshall, C. In: Briefings. RePEc:ohe:briefg:001835. Full description at Econpapers || Download paper | 1 |
| 29 | 2018 | Private Provision of Publicly Funded Health Care: The Economics of Ownership. (2018). Chalkley, Martin ; Sussex, J. In: Briefings. RePEc:ohe:briefg:002055. Full description at Econpapers || Download paper | 1 |
| 30 | 1991 | Factors Influencing Clinical Decisions in General Practice. (1991). Of, Office . In: Briefings. RePEc:ohe:briefg:000385. Full description at Econpapers || Download paper | 1 |
| 31 | 2019 | Indication-Based Pricing (IBP) Discussion Paper: Should drug prices differ by indication?. (2019). Zamora, B ; Towse, A ; Cole, A. In: Briefings. RePEc:ohe:briefg:002165. Full description at Econpapers || Download paper | 1 |
| 32 | 2008 | Health Care Services and the Single European Market. (2008). Mountford, L ; Dawson, D. In: Briefings. RePEc:ohe:briefg:000240. Full description at Econpapers || Download paper | 1 |
| 33 | 2022 | Quality of life and wellbeing in individuals with experience of fertility problems and assisted reproductive techniques. (2022). Of, Office. In: Briefing. RePEc:ohe:briefg:002460. Full description at Econpapers || Download paper | 1 |
| 34 | 1982 | Ill in Europe. (1982). Vaizey, J. In: Briefings. RePEc:ohe:briefg:000329. Full description at Econpapers || Download paper | 1 |
| 35 | 2003 | Reducing Harm to Patients in the National Health Service. Will the Governments Compensation Proposals Help?. (2003). Towse, Adrian ; Gray, Alastair ; Salinas, R ; Rickman, N ; Fenn, P. In: Briefings. RePEc:ohe:briefg:000484. Full description at Econpapers || Download paper | 1 |
| 36 | 2021 | 2020 OHE Annual Report to the Charity Commission. (2021). Of, Office. In: Briefings. RePEc:ohe:briefg:002403. Full description at Econpapers || Download paper | 1 |
| 37 | 1980 | Effects of Prescription Charges. (1980). Of, Office . In: Briefings. RePEc:ohe:briefg:000310. Full description at Econpapers || Download paper | 1 |
50 most relevant documents in this series (papers most cited in the last two years)
| # | Year | Title | Cited |
|---|---|---|---|
| 1 | 2017 | Additional Elements of Value for Health Technology Assessment Decisions. (2017). Towse, Adrian ; Karlsberg, Sarah ; Karlsberg Schaffer, Sarah ; Fischer, A ; Masterson, R ; Mestre-Ferrandiz, J ; Henshall, C ; West, P. In: Briefings. RePEc:ohe:briefg:001851. Full description at Econpapers || Download paper | 3 |
| 2 | 2019 | How Should We Measure Quality of Life Impact in Rare Disease? Recent Learnings in Spinal Muscular Atrophy. (2019). Sampson, Christopher ; Garau, M. In: Briefings. RePEc:ohe:briefg:002146. Full description at Econpapers || Download paper | 2 |
| 3 | 2018 | Multi-Indication Pricing (MIP): Practical Solutions and Steps to Move Forward. (2018). Neri, Margherita ; Garau, Martina ; Towse, A. In: Briefings. RePEc:ohe:briefg:002084. Full description at Econpapers || Download paper | 2 |
Citing documents used to
compute impact factor: 2
| Year | Title | |
|---|---|---|
| 2023 | Predicting SMEsâ default risk: Evidence from bank-firm relationship data. (2023). Formisano, Vincenzo ; Gallucci, Carmen ; Pietrovito, Filomena ; Modina, Michele. In: The Quarterly Review of Economics and Finance. RePEc:eee:quaeco:v:89:y:2023:i:c:p:254-268. Full description at Econpapers || Download paper | |
| 2023 | Unmet Parenthood Goals, Health-Related Quality of Life and Apparent Irrationality: Understanding the Value of Treatments for Infertility. (2023). Gameiro, Sofia ; Mott, David ; Cubi-Molla, Patricia ; Skedgel, Chris ; Jofre-Bonet, Mireia ; Andersson, Fredrik L ; Markert, Marie ; Brazier, John ; Al-Janabi, Hareth ; Boivin, Jacky. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:7:y:2023:i:3:d:10.1007_s41669-023-00402-5. Full description at Econpapers || Download paper |
Recent citations
10 most frequent citing series